Nautilus Biotechnology Inc (NAUT)

Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.16%0.23	0.19	-	-	-
Cost Of Revenue	60.00%0.02	0.02	-	-	-
	6.33%16.95	15.94	16.12	15.42	15.47
Selling, General, and Administrative	7.05%6.77	6.33	6.42	-	-
Research and Development	5.86%10.18	9.61	9.71	9.58	9.61
Nonoperating Income/Loss	14.91%1.10	1.29	1.43	1.64	1.90
Income Tax Expense/Benefit	-	-	-	-	-
	8.07%-15.64	-14.47	-14.70	-13.78	-13.57
Attributable To Parent	8.07%-15.64	-14.47	-14.70	-13.78	-13.57
Available To Common Stockholders, Basic	8.07%-15.64	-14.47	-14.70	-13.78	-13.57
Basic Average Shares	0.08%127.24	127.14	126.63	0.04	126.31
Diluted Average Shares	0.08%127.24	127.14	126.63	0.04	126.31
Basic Earnings Per Share	9.09%-0.12	-0.11	-0.12	-0.11	-0.11
Diluted Earnings Per Share	9.09%-0.12	-0.11	-0.12	-0.11	-0.11